2013
DOI: 10.1097/prs.0b013e318290f8a0
|View full text |Cite
|
Sign up to set email alerts
|

Implant-Based Breast Reconstruction Using a Titanium-Coated Polypropylene Mesh (TiLOOP Bra)

Abstract: Risk, III.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
74
2
9

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 116 publications
(98 citation statements)
references
References 34 publications
3
74
2
9
Order By: Relevance
“…The use of ADM presents no significant increase of longterm complication rates and less capsular contracture compared to 2stage expander/im plant reconstruction without ADM (LoE 2b, C) [65]. Syn thetic meshes can be used in patients undergoing reconstruc tion after SSM or NSM with wellpreserved skin softtissue proportions and in patients with primary or secondary pro phylactic subcutaneous mastectomy; they seem to be a helpful tool for implant stabilization in terms of lateral stabilization and fixation of the musculus pectoralis major [66].…”
Section: Ductal Carcinoma In Situmentioning
confidence: 99%
“…The use of ADM presents no significant increase of longterm complication rates and less capsular contracture compared to 2stage expander/im plant reconstruction without ADM (LoE 2b, C) [65]. Syn thetic meshes can be used in patients undergoing reconstruc tion after SSM or NSM with wellpreserved skin softtissue proportions and in patients with primary or secondary pro phylactic subcutaneous mastectomy; they seem to be a helpful tool for implant stabilization in terms of lateral stabilization and fixation of the musculus pectoralis major [66].…”
Section: Ductal Carcinoma In Situmentioning
confidence: 99%
“…First clinical results show increased complications rates in patients undergoing secondary IBBR using TiLOOP Ò Bra [25]. In these secondary cases poor soft tissue conditions are frequently found.…”
Section: Discussionmentioning
confidence: 98%
“…As continuing advancements in technology and bioprosthetic design are realized, different implant characteristics and nonhuman acellular dermal matrix may illustrate improved cost efficacy, which has yet to be explored adequately. 12,42,53,54 Similarly, patient-reported outcomes and quality of life are quickly growing foci in health care outcomes research. Incorporating these aspects in reconstructive modality comparisons is vital to optimizing patient outcomes.…”
Section: Limitations and Future Considerationsmentioning
confidence: 99%